Malebari, A.M.; Wang, S.; Greene, T.F.; O’Boyle, N.M.; Fayne, D.; Khan, M.F.; Nathwani, S.M.; Twamley, B.; McCabe, T.; Zisterer, D.M.;
et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119.
https://doi.org/10.3390/ph14111119
AMA Style
Malebari AM, Wang S, Greene TF, O’Boyle NM, Fayne D, Khan MF, Nathwani SM, Twamley B, McCabe T, Zisterer DM,
et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals. 2021; 14(11):1119.
https://doi.org/10.3390/ph14111119
Chicago/Turabian Style
Malebari, Azizah M., Shu Wang, Thomas F. Greene, Niamh M. O’Boyle, Darren Fayne, Mohemmed Faraz Khan, Seema M. Nathwani, Brendan Twamley, Thomas McCabe, Daniela M. Zisterer,
and et al. 2021. "Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4" Pharmaceuticals 14, no. 11: 1119.
https://doi.org/10.3390/ph14111119
APA Style
Malebari, A. M., Wang, S., Greene, T. F., O’Boyle, N. M., Fayne, D., Khan, M. F., Nathwani, S. M., Twamley, B., McCabe, T., Zisterer, D. M., & Meegan, M. J.
(2021). Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals, 14(11), 1119.
https://doi.org/10.3390/ph14111119